257 related articles for article (PubMed ID: 8228996)
1. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.
Vandermeeren M; Mercken M; Vanmechelen E; Six J; van de Voorde A; Martin JJ; Cras P
J Neurochem; 1993 Nov; 61(5):1828-34. PubMed ID: 8228996
[TBL] [Abstract][Full Text] [Related]
2. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.
Hu YY; He SS; Wang X; Duan QH; Grundke-Iqbal I; Iqbal K; Wang J
Am J Pathol; 2002 Apr; 160(4):1269-78. PubMed ID: 11943712
[TBL] [Abstract][Full Text] [Related]
3. [Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease].
Arai H; Satoh K; Terajima M; Nakagawa T; Higuchi M; Kosaka Y; Zhu C; Sasaki H
Nihon Ronen Igakkai Zasshi; 1996 Sep; 33(9):669-75. PubMed ID: 8940864
[TBL] [Abstract][Full Text] [Related]
4. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid tau in patients with Alzheimer's disease.
Jensen M; Basun H; Lannfelt L
Neurosci Lett; 1995 Feb; 186(2-3):189-91. PubMed ID: 7777193
[TBL] [Abstract][Full Text] [Related]
6. Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
Lewczuk P; Lelental N; Lachmann I; Holzer M; Flach K; Brandner S; Engelborghs S; Teunissen CE; Zetterberg H; Molinuevo JL; Mroczko B; Blennow K; Popp J; Parnetti L; Chiasserini D; Perret-Liaudet A; Spitzer P; Maler JM; Kornhuber J
J Alzheimers Dis; 2017; 55(1):159-170. PubMed ID: 27662295
[TBL] [Abstract][Full Text] [Related]
7. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.
Vigo-Pelfrey C; Seubert P; Barbour R; Blomquist C; Lee M; Lee D; Coria F; Chang L; Miller B; Lieberburg I
Neurology; 1995 Apr; 45(4):788-93. PubMed ID: 7723971
[TBL] [Abstract][Full Text] [Related]
8. Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.
Yamamori H; Khatoon S; Grundke-Iqbal I; Blennow K; Ewers M; Hampel H; Iqbal K
Neurosci Lett; 2007 May; 418(2):186-9. PubMed ID: 17400380
[TBL] [Abstract][Full Text] [Related]
9. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.
Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB
Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492
[TBL] [Abstract][Full Text] [Related]
11. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.
Green AJ; Harvey RJ; Thompson EJ; Rossor MN
Neurosci Lett; 1999 Jan; 259(2):133-5. PubMed ID: 10025576
[TBL] [Abstract][Full Text] [Related]
12. Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.
Barthélemy NR; Gabelle A; Hirtz C; Fenaille F; Sergeant N; Schraen-Maschke S; Vialaret J; Buée L; Junot C; Becher F; Lehmann S
J Alzheimers Dis; 2016; 51(4):1033-43. PubMed ID: 26923020
[TBL] [Abstract][Full Text] [Related]
13. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
Leszek J; Małyszczak K; Janicka B; Kiejna A; Wiak A
Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
[TBL] [Abstract][Full Text] [Related]
14. Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity.
Holzer M; Holzapfel HP; Zedlick D; Brückner MK; Arendt T
Neuroscience; 1994 Nov; 63(2):499-516. PubMed ID: 7891861
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
16. Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease.
Santos JRF; Bauer C; Schuchhardt J; Wedekind D; Waniek K; Lachmann I; Wiltfang J; Vogelgsang J
J Neural Transm (Vienna); 2019 Mar; 126(3):339-348. PubMed ID: 30767082
[TBL] [Abstract][Full Text] [Related]
17. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Blennow K; Wallin A; Agren H; Spenger C; Siegfried J; Vanmechelen E
Mol Chem Neuropathol; 1995 Dec; 26(3):231-45. PubMed ID: 8748926
[TBL] [Abstract][Full Text] [Related]
18. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.
Arai H; Terajima M; Miura M; Higuchi S; Muramatsu T; Machida N; Seiki H; Takase S; Clark CM; Lee VM
Ann Neurol; 1995 Oct; 38(4):649-52. PubMed ID: 7574462
[TBL] [Abstract][Full Text] [Related]
19. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
[TBL] [Abstract][Full Text] [Related]
20. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.
Iqbal K; Flory M; Khatoon S; Soininen H; Pirttila T; Lehtovirta M; Alafuzoff I; Blennow K; Andreasen N; Vanmechelen E; Grundke-Iqbal I
Ann Neurol; 2005 Nov; 58(5):748-57. PubMed ID: 16247771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
